Baidu
map

有症状的股骨髋臼撞击关节镜矫正后 10 年的存活率和临床结果

2022-01-18 MedSci原创 MedSci原创

股骨髋臼撞击 (FAI) 是一种常见的机械性髋关节疾病,在运动员和普通人群中都很普遍。手术干预是一种有效的治疗选择,可在中短期随访中改善症状和功能。而文献中很少有研究报告关节镜手术的长期成功结果。

股骨髋臼撞击 (FAI) 是一种常见的机械性髋关节疾病,在运动员和普通人群中都很普遍。手术干预是一种有效的治疗选择,可在中短期随访中改善症状和功能。而文献中很少有研究报告关节镜手术的长期成功结果。

该研究的目的是量化接受关节镜治疗的症状性 FAI 患者的 10 年生存率和临床结果。

图1 文章来源

该研究团队所登记髋关节患者 (n = 119) 完成了患者报告的结果测量 (PROM),包括修改后的 Harris 髋关节评分 (mHHS)、加州大学洛杉矶分校 (UCLA) 活动量表、36 项简短健康调查 (SF- 36),西安大略和麦克马斯特大学骨关节炎指数(WOMAC)在关节镜检查后至少 10 年(范围,10-12 年),并使用 Wilcoxon 符号秩检验将结果与基线分数比较。

使用卡方分析分析了几个预后因素之间的关联,包括年龄、性别、Tönnis 分级和盂唇

治疗,以及随后转换为全髋关节置换术 (THR) 或重复髋关节镜检查 (RHA)。还使用 Pearson 相关分析检查了运动范围和放射学结果与临床结果之间的关系。

使用分布法(变化评分的 0.5 标准差)计算最小临床重要差异 (MCID),使用锚定法确定显着临床获益 (SCB)。最后,使用接受者操作特征曲线和随后的约登指数来确定 PROM 的截止值,这相当于患者可接受的症状状态 (PASS)。

结果显示,共有 8.4% 的病例需要转换为 THR,5.9% 的病例需要 RHA。术后 10 年观察到 mHHS、SF-36 和 WOMAC 评分显着改善,满意度高(90%)。

图 2Kaplan-Meier 曲线表示基于 Tönnis 等级的随时间(年)的累积 (Cum) 存活率

尽管患者术后已过10 年,但活动水平(UCLA 评分)没有显着变化。高比例的患者在 mHHS (88%)、SF-36 (84%) 和 WOMAC (60%) 方面实现了 MCID。大多数患者还达到了 PASS(mHHS 为 62%,UCLA 为 85%,SF-36 为 78%,WOMAC 为 84%)和 SCB(mHHS 为 74%,UCLA 为 58%,SF-36 为 52% ,而 WOMAC 为 56%)。

对于有症状的 FAI 患者,关节镜干预是一种安全可行的治疗选择,患者可以期待长期改善和高满意度。结果表明,在初次手术后 10 年,患者的满意度(90%)和存活率(91.6%)很高,临床结果非常好。

原始文章:

Carton P, Filan D, Mullins K. Survivorship Rate and Clinical Outcomes 10 Years After Arthroscopic Correction of Symptomatic Femoroacetabular Impingement. Am J Sports Med. 2022 Jan;50(1):19-29. doi: 10.1177/03635465211055485. Epub 2021 Nov 19. PMID: 34796726.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1898885, encodeId=3ec318988859e, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22969, encryptionId=729322969b9, topicName=临床结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Sun Jul 31 03:46:27 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862999, encodeId=03401862999a2, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Jan 22 01:46:27 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418886, encodeId=f40f141888657, content=<a href='/topic/show?id=9cd3301521d' target=_blank style='color:#2F92EE;'>#关节镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30152, encryptionId=9cd3301521d, topicName=关节镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7693435830, createdName=xzw114, createdTime=Fri Jan 14 12:46:27 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529753, encodeId=03001529e5327, content=<a href='/topic/show?id=70ff81e9156' target=_blank style='color:#2F92EE;'>#股骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81791, encryptionId=70ff81e9156, topicName=股骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3011964327, createdName=wangyang7962, createdTime=Fri Jan 14 12:46:27 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1898885, encodeId=3ec318988859e, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22969, encryptionId=729322969b9, topicName=临床结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Sun Jul 31 03:46:27 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862999, encodeId=03401862999a2, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Jan 22 01:46:27 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418886, encodeId=f40f141888657, content=<a href='/topic/show?id=9cd3301521d' target=_blank style='color:#2F92EE;'>#关节镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30152, encryptionId=9cd3301521d, topicName=关节镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7693435830, createdName=xzw114, createdTime=Fri Jan 14 12:46:27 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529753, encodeId=03001529e5327, content=<a href='/topic/show?id=70ff81e9156' target=_blank style='color:#2F92EE;'>#股骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81791, encryptionId=70ff81e9156, topicName=股骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3011964327, createdName=wangyang7962, createdTime=Fri Jan 14 12:46:27 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1898885, encodeId=3ec318988859e, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22969, encryptionId=729322969b9, topicName=临床结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Sun Jul 31 03:46:27 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862999, encodeId=03401862999a2, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Jan 22 01:46:27 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418886, encodeId=f40f141888657, content=<a href='/topic/show?id=9cd3301521d' target=_blank style='color:#2F92EE;'>#关节镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30152, encryptionId=9cd3301521d, topicName=关节镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7693435830, createdName=xzw114, createdTime=Fri Jan 14 12:46:27 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529753, encodeId=03001529e5327, content=<a href='/topic/show?id=70ff81e9156' target=_blank style='color:#2F92EE;'>#股骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81791, encryptionId=70ff81e9156, topicName=股骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3011964327, createdName=wangyang7962, createdTime=Fri Jan 14 12:46:27 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
    2022-01-14 xzw114
  4. [GetPortalCommentsPageByObjectIdResponse(id=1898885, encodeId=3ec318988859e, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22969, encryptionId=729322969b9, topicName=临床结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd6156, createdName=oliver169, createdTime=Sun Jul 31 03:46:27 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862999, encodeId=03401862999a2, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Jan 22 01:46:27 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418886, encodeId=f40f141888657, content=<a href='/topic/show?id=9cd3301521d' target=_blank style='color:#2F92EE;'>#关节镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30152, encryptionId=9cd3301521d, topicName=关节镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7693435830, createdName=xzw114, createdTime=Fri Jan 14 12:46:27 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529753, encodeId=03001529e5327, content=<a href='/topic/show?id=70ff81e9156' target=_blank style='color:#2F92EE;'>#股骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81791, encryptionId=70ff81e9156, topicName=股骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3011964327, createdName=wangyang7962, createdTime=Fri Jan 14 12:46:27 CST 2022, time=2022-01-14, status=1, ipAttribution=)]

相关资讯

关节镜下股骨头颈成形术有效治疗股骨髋臼撞击症

图示关节镜下盂唇成形术: a,b:关节镜下见髋臼盂唇损伤的镜下照片与示意图; c,d:关节镜下行盂唇成形术的镜下照片与示意图,切除损伤的盂唇组织女修整切面。        上海复旦大学附属华山医院运动医学科吴子英等的一项研究证实,髋关节镜下股骨头颈成形术能够切除股骨头颈结合部骨性隆起,恢复股骨头颈结合部的自然弧度,有效缓解凸轮型(Cam型)股骨髋臼

拓展阅读

BMJ:膝关节疼痛 慎行关节镜

最新研究表明:对于因为罹患骨关节炎而感到持续膝关节疼痛的中老年患者,关节镜手术并没有明显疗效。而且更可能会造成潜在损伤。相关文章发表在近期BMJ上。 此篇报道属于BMJ期刊的“过度医疗”系列之一,此系列旨在呼吁人们关注因为过度医疗而导致的健康损害和医疗资源浪费。在美国和英国,共有超过850,000的中老年患者因为持续膝关节疼痛而接受了关节镜手术,然而这类手术的相关循证证据等级

Baidu
map
Baidu
map
Baidu
map